Back to search
Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer.
Data up to Jan 2025
Published1996
Citations66
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...